Skip to main content
SpringerLink
Log in

Anxiety Disorders

  • Chapter
Book cover Fundamentals of Family Medicine

  • 226 Accesses

Abstract

Anxiety disorders are among the most frequently occurring mental disorders in the general population. They encompass a group of conditions that share pathologic anxiety as a principal disturbance of mood with resultant effects on thought, behavior, and physiologic activity. This category of disorders includes panic disorder with agoraphobia, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, and posttraumatic stress disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994; 411–7.

    Google Scholar 

  2. Eaton WW, Kessler RC, Wittchen HU, Magee WJ. Panic and panic disorder in the United States. Am J Psychiatry 1994; 151: 413–20.

    PubMed  CAS  Google Scholar 

  3. Marshall JR. Alcohol and substance abuse in panic disorder. J Clin Psychiatry 1997; 58 (suppl 2): 46–9.

    PubMed  Google Scholar 

  4. Gorman J. Recent developments in understanding panic disorder leading to improved treatment strategies. Primary Psychiatry 1996; 3: 31–8.

    Google Scholar 

  5. Roy-Byrne PP, Stein MB, Russo J. Panic disorder in the primary care setting: co-morbidity, disability, service utilization, and treatment. J Clin Psychiatry 1999; 60: 492–9.

    Article  PubMed  CAS  Google Scholar 

  6. Liebowitz MR. Panic disorder as a chronic illness. J Clin Psychiatry 1997; 58 (suppl 13): 5–8.

    PubMed  Google Scholar 

  7. Nutt DJ. Antidepressants in panic disorder: clinical and preclinical mechanisms J Clin Psychiatry 1998; 59 (suppl 8): 24–8.

    CAS  Google Scholar 

  8. Vanin JR, Vanin SK. Blocking the cycle of panic disorder: ways to gain control of the fear of fear. Postgrad Med 1999; 105: 141–6.

    Article  PubMed  CAS  Google Scholar 

  9. Saeed SA, Bruce TJ. Panic disorder: effective treatment options. Am Fam Physician 1998; 57: 2405–12.

    PubMed  CAS  Google Scholar 

  10. Mavissakalian MR, Perel JM. Imipramine treatment of panic disorder with agoraphobia. J Psychiatry 1995; 152: 673–82.

    CAS  Google Scholar 

  11. Schweizer E, Rickels K. Strategies for treatment of generalized anxiety in the primary care setting. J Clin Psychiatry 1997; 58 (suppl 3): 76–80.

    Google Scholar 

  12. Rickels K, Schweizer E. The clinical course and long-term management of generalized anxiety disorder. J Clin Psychopharmacol 1990; 10: 101–8.

    Article  Google Scholar 

  13. Wise MG, Griffies WS. A combined treatment approach to anxiety in the medically ill. J Clin Psychiatry 1995; 56 (suppl 2): 14–19.

    PubMed  Google Scholar 

  14. Noyes R, Woodman C, Garvey MJ, et al. Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity. J Nerv Ment Dis 1992; 180: 369–79.

    Article  PubMed  Google Scholar 

  15. Taylor CB, Sallis JF, Needle R. Relation of physical activity and exercise to mental health. Public Health Rep 1985; 100: 195–202.

    PubMed  CAS  Google Scholar 

  16. Mathews A. Why worry? The cognitive function of anxiety. Behav Res Ther 1990; 28: 455–68.

    Article  PubMed  CAS  Google Scholar 

  17. Butler G, Fennell M, Robson P, Gelder M. Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 1991; 59: 167–75.

    Article  PubMed  CAS  Google Scholar 

  18. Schweizer E. Generalized anxiety disorder. Longitudinal course and pharmacologic treatment. Psychiatr Clin North Am 1995; 18: 843–57.

    PubMed  CAS  Google Scholar 

  19. Shorr RI, Robin DW. Rational use of benzodiazepines in the elderly. Drugs Aging 1994; 4: 9–20.

    Article  PubMed  CAS  Google Scholar 

  20. Davidson JR, DuPont RL, Hedges D, Haskins JT. Efficacy, safety and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999; 60 (8): 528–35.

    Article  PubMed  CAS  Google Scholar 

  21. Silverstone PH, Ravindran A. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety: Venlafaxine XR 360 Study Group. J Clin Psychiatry 1999; 60 (1): 22–8.

    Article  PubMed  CAS  Google Scholar 

  22. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM. Social phobia: comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry 1992; 49: 282–8.

    Article  PubMed  CAS  Google Scholar 

  23. Kessler RC, McGonagle DK, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Co-morbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19.

    Article  PubMed  CAS  Google Scholar 

  24. Ost LG, Hugdahl K. Acquisition of phobias and anxiety response patterns in clinical patients. Behav Res Ther 1981; 19: 439–47.

    Article  PubMed  CAS  Google Scholar 

  25. Schneier FR, Martin LY, Liebowitz MR, Gorman JM, Fyer AJ. Alcohol abuse in social phobia. J Anx Disord 1989; 3: 15–23.

    Article  Google Scholar 

  26. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990; 147: 685–95.

    PubMed  CAS  Google Scholar 

  27. Bruce TJ, Saeed SA. Social anxiety disorder: a common, underrecognized mental disorder. Am Fam Physician 1999; 60: 2311–22.

    PubMed  CAS  Google Scholar 

  28. Juster HR, Heimberg RG. Social phobia: longitudinal course and long-term outcome of cognitive-behavioral treatment. Psychiatr Clin North Am 1995; 18: 821–42.

    PubMed  CAS  Google Scholar 

  29. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 1998; 280: 708–13.

    Article  PubMed  CAS  Google Scholar 

  30. Bouwer C, Stein DJ. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia. J Affect Disord 1998; 49: 79–82.

    Article  PubMed  CAS  Google Scholar 

  31. Davidson JR, Potts N, Richichi E, Krishnan R, Ford SM, Smith R. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993; 13: 423–8.

    Article  PubMed  CAS  Google Scholar 

  32. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br J Psychiatry 1992; 161: 353–60.

    Article  PubMed  CAS  Google Scholar 

  33. Turner SM, Beidel DC, Jacob RD. Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol 1994; 62: 350–8.

    Article  PubMed  CAS  Google Scholar 

  34. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiartry 1988; 45: 1094–9.

    Article  CAS  Google Scholar 

  35. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol 1997; 65: 44–52.

    Article  PubMed  CAS  Google Scholar 

  36. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 1995; 52: 53–60.

    Article  PubMed  CAS  Google Scholar 

  37. Kessler RC, Sonnega A, Bromet E. Posttraumatic stress disorder in the National Co-morbidity Study. Arch Gen Psychiatry 195; 52: 1048–60.

    Google Scholar 

  38. Brady KT. Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD. J Clin Psychiatry 1997; 58 (suppl 9): 12–5.

    PubMed  Google Scholar 

  39. Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 2000; 61 (suppl 5): 4–12.

    PubMed  Google Scholar 

  40. Blank AS Jr. Clinical detection, diagnosis, and differential diagnosis of post-traumatic stress disorder. Psychiatr Clin North Am 1994; 17: 351–83.

    PubMed  Google Scholar 

  41. Foa EB, Heast-Ikeda D, Perry KJ. Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims. J Consult Clin Psychol 1995; 63: 948–55.

    Article  PubMed  CAS  Google Scholar 

  42. Brady KT, Sonne SC, Roberts JM. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry 1995; 56: 502–5.

    PubMed  CAS  Google Scholar 

  43. Marmar CR, Schoenfeld F, Weiss DS, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996; 57 (suppl 8): 66–72.

    PubMed  CAS  Google Scholar 

  44. Friedman MJ. Current and future drug treatment for posttraumatic stress disorder patients. Psychiatr Ann 1998; 28: 461–8.

    Google Scholar 

  45. Silver JM, Sandberg DP, Hales RE. New approaches in the pharmacotherapy of PTSD. J Clin Psychiatry 1990; 51 (suppl 10): 33–8.

    Google Scholar 

Download references

Authors
  1. Deborah S. McPherson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health & Science University School of Medicine, Portland, Oregon, USA

    Robert B. Taylor M.D. (Professor of Family Medicine) (Professor of Family Medicine)

  2. Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Alan K. David M.D. (Professor and Chairman) (Professor and Chairman)

  3. Department of Family Medicine, Oregon Health & Science University School of Medicine, Portland, Oregon, USA

    Scott A. Fields M.D. (Professor and Vice Chairman) (Professor and Vice Chairman)

  4. Department of Family Medicine, University of Mississippi School of Medicine, Jackson, Mississippi, USA

    D. Melessa Phillips M.D. (Professor and Chairman) (Professor and Chairman)

  5. College of Medicine, Florida State University College of Medicine, Tallahassee, Florida, USA

    Joseph E. Scherger M.D., M.P.H. (Dean) (Dean)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

McPherson, D.S. (2003). Anxiety Disorders. In: Taylor, R.B., David, A.K., Fields, S.A., Phillips, D.M., Scherger, J.E. (eds) Fundamentals of Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-21745-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-21745-1_22

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95479-0

  • Online ISBN: 978-0-387-21745-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation